1 / 65

Gérard Friedlander , MD, PhD

OSTEOSCOOP WEBINAR Cellular regulators of bone remodeling in health and disease: a step to molecular medicine. Gérard Friedlander , MD, PhD. Growth factors. M-CSF augments RANKL-induced resorption in mature human osteoclasts. RANKL. Osteoclast. RANK. Cell differentiation.

britanni-allison
Download Presentation

Gérard Friedlander , MD, PhD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OSTEOSCOOP WEBINARCellular regulators of bone remodeling in health and disease: a step to molecular medicine Gérard Friedlander, MD, PhD

  2. Growth factors

  3. M-CSF augments RANKL-induced resorption in mature human osteoclasts

  4. RANKL Osteoclast RANK Cell differentiation Pre-osteoclast Osteoclast Activation Bone resorption

  5. RANKL Osteoclast RANK Cell differentiation Pre-osteoclast + M-CSF + Osteoclast Activation 200 – 300% increase Bone resorption

  6. RANKL Osteoclast RANK Cell differentiation Pre-osteoclast + M-CSF + Osteoclast Activation 200 – 300% increase MEK-P ERK1/2-P c-fos Bone resorption favors Mature Osteoclast

  7. RANKL Osteoclast RANK Cell differentiation Pre-osteoclast + M-CSF + Osteoclast Activation 200 – 300% increase MEK P inhibitor PD98059 MEK-P ERK1/2-P c-fos Bone resorption favors Mature Osteoclast

  8. Epidermal Growth Factor Receptor plays an anabolic role in bone

  9. EGFR Osteoblast

  10. EGFR ligands HBEGF Epigen Amphiregulin Epiregulin Betacellulin TGF EGF EGFR Osteoblast

  11. EGFR ligands HBEGF Epigen Amphiregulin Epiregulin Betacellulin TGF EGF EGFR P P Osteoblast

  12. EGFR ligands HBEGF Epigen Amphiregulin Epiregulin Betacellulin TGF EGF EGFR P P Signaling pathways Osteoblast

  13. EGFR ligands HBEGF Epigen Amphiregulin Epiregulin Betacellulin TGF EGF EGFR P P Signaling pathways Osteoblast Reduced bone resorption Increased bone formation Increased bone volume and mineral density

  14. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells

  15. IGF-1 release Osteoblasts Osteoclasts Bone resorption Bone formation IGF-1

  16. Mesenchymal Stem cell Osteoblast differentiation Pre-osteoblast + mTOR Igf1r IGF-1 release Osteoblasts Osteoclasts Bone resorption Bone formation IGF-1

  17. Mesenchymal Stem cell Osteoblast differentiation Pre-osteoblast + mTOR Igf1r IGF-1 release Osteoblasts Osteoclasts Bone resorption Bone formation IGF-1 Young rat Low bone matrix IGF-1 Low bone formation IGF-1 Aged rat

  18. Mesenchymal Stem cell Osteoblast differentiation Pre-osteoblast + mTOR Igf1r IGF-1 release Osteoblasts Osteoclasts Bone resorption Bone formation IGF-1 Young rat Low bone matrix IGF-1 Low bone formation Higher bone matrix IGF-1 Higher bone formation IGF-1 + IGFBP3 IGF-1 IGF-1 Aged rat Aged rat

  19. Signaling pathways

  20. Physiological function of the Angiotensin AT1a receptor inbone remodeling

  21. Kidney Pre-osteoblast Renin ACE AT1a Liver Angiotensinogen Angiotensin I Angiotensin II Massive bone resorption

  22. Kidney Pre-osteoblast Renin ACE AT1a Liver Angiotensinogen Angiotensin I Angiotensin II Pre-osteoblast Massive boneresorption AT1a Increase bone mass

  23. Kidney Pre-osteoblast Renin ACE AT1a Liver Angiotensinogen Angiotensin I Angiotensin II Pre-osteoblast AT1a Massive boneresorption AT1a Osteocyte Increase bone mass RANKL OPG Sclerostin Osteoblasts Osteoclasts Bone Resorption Bone formation

  24. Osteoblast extracellular Ca2+ sensing receptor regulates bone development, mineralization and turnover

  25. Ca2+ Ca2+ Ca2+ Ca2+ Ca2+ CaR Pre-osteoblast

  26. Ca2+ Ca2+ Ca2+ Ca2+ Ca2+ CaR Pre-osteoblast WT CaR KO • Lower trabecular bone volume • Higher cortical bone porosity • Altered mineralization • Lower BMD • Smaller and lighter mouse • Frequent fractures • Died at 3-4 weeks old

  27. Ca2+ Ca2+ Ca2+ Ca2+ Altered osteoblast differentiation Affect bone formation and bone mineralization OPG CaR Ca2+ CaR NPP1 RANKL ANK OPN Pre-osteoblast RANKL Favors bone resorption RANK Pre-osteoclast WT CaR KO • Lower trabecular bone volume • Higher cortical bone porosity • Altered mineralization • Lower BMD • Smaller and lighter mouse • Frequent fractures • Died at 3-4 weeks old

  28. Targeting osteoclast – osteoblast communication

  29. Osteoclast progenitor Bone marrow mesenchymal cell Osteoclast precursor Pre-osteoblasts Osteoblasts Osteoclasts Osteocytes BONE RESORPTION BONE FORMATION

  30. RANKL Osteoclast progenitor Bone marrow mesenchymal cell RANK Osteoclast precursor Pre-osteoblasts OPG Osteoblasts Osteoclasts Osteocytes BONE RESORPTION BONE FORMATION

  31. RANKL Osteoclast progenitor Bone marrow mesenchymal cell RANK Osteoclast precursor Pre-osteoblasts OPG TGF-b1 Induce migration Osteoblasts Osteoclasts Osteocytes BONE RESORPTION BONE FORMATION

  32. RANKL Osteoclast progenitor Bone marrow mesenchymal cell RANK Osteoclast precursor Pre-osteoblasts OPG TGF-b1 Induce migration Sema4D Plexin B1 Osteoblasts Osteoclasts Osteocytes BONE RESORPTION BONE FORMATION

  33. Regulation of RANKL-induced osteoclastogenesis by TGF-b through molecular interaction between Smad3 and Traf6

  34. TGF-b TGF-b receptor RANKL RANK TAB1 TAB2 TAK1 TRAF6 TRAF6 TAB2 TAK1 TAB1 Osteoclastogenesis JNK JNK-P MAP38 MAP38-P

  35. TGF-b MH2 Smad3 Smad2 TGF-b receptor Smad3/Smad2/Smad4 RANKL RANK TAB1 TAB2 TAK1 TRAF6 TRAF6 TAB2 TAK1 TAB1 Osteoclastogenesis JNK JNK-P MAP38 MAP38-P

  36. TGF-b MH2 Smad3 Smad2 TGF-b receptor Smad3/Smad2/Smad4 RANKL RANK TAB1 TAB2 TAK1 Smad3/Smad2/Smad4 TRAF6 TRAF6 TAB2 TAK1 TAB1 Osteoclastogenesis JNK JNK-P MAP38 MAP38-P

  37. Overexpression of Secreted Frizzled-Related Protein 1 Inhibits Bone Formation and Attenuates Parathyroid Hormone Bone Anabolic Effects

  38. Wnt Enhanced osteoblast differentiation Frizzled -catenin PTH PTH-R

  39. sFRP 1 Wnt Enhanced osteoblast differentiation Frizzled -catenin PTH PTH-R

  40. sFRP 1 Wnt Enhanced osteoblast differentiation Frizzled X -catenin PTH Osteopenia PTH-R

  41. sFRP 1 Wnt Enhanced osteoblast differentiation + Frizzled X -catenin PTH Osteopenia PTH-R

  42. sFRP 1 Wnt Enhanced osteoblast differentiation + Frizzled X X -catenin PTH Osteopenia PTH-R

  43. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength

  44. BMP2/4 BMPR1A Smad1 P Smad4 P Smad5 Smad8 P Pre-osteoblast

  45. BMP2/4 BMPR1A-mFC mFC Osteoblasts Increase osteoblast differentiation BMPR1A Increasebone formation Smad1 P Smad4 P Smad5 Smad8 LowDKK1 P Pre-osteoblast

  46. BMP2/4 BMPR1A-mFC mFC Osteoblasts Increase osteoblast differentiation BMPR1A Increasebone formation Smad1 P Smad4 Pre-osteoclast P Smad5 Smad8 Decrease osteoclast differentiation LowDKK1 P Osteoclast LowRANKL Decrease bone resorption Pre-osteoblast

  47. BMP2/4 BMPR1A-mFC mFC Osteoblasts Increase osteoblast differentiation BMPR1A Increasebone formation Smad1 P Smad4 Low bone mass Pre-osteoclast P Smad5 Smad8 Decrease osteoclast differentiation LowDKK1 P Osteoclast LowRANKL Decrease bone resorption Pre-osteoblast BMPR1A-mFC Increase bone mass Ovx mouse

  48. Local mediators and regulatory proteins

  49. EP1−/− mice have enhanced osteoblast differentiation and accelerated fracture repair

  50. Arachidonic acid PGE2 COX-2

More Related